<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0019">
 <label>19.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Muir</surname>
    <given-names>AJ</given-names>
   </name>, 
   <name name-style="western">
    <surname>Arora</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Everson</surname>
    <given-names>G</given-names>
   </name>, 
   <etal>et al;</etal>
  </person-group>
  <person-group>
   <collab>EMERGE Study Group</collab>
  </person-group>
  <article-title>A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection</article-title>. 
  <source>J Hepatol</source>
  <year>2014</year>; 
  <volume>61</volume>:
  <fpage>1238</fpage>â€“
  <lpage>46</lpage>.
  <pub-id pub-id-type="pmid">25064437</pub-id>
 </mixed-citation>
</ref>
